Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 448 followers
Latest posts
Last updated about 19 hours ago
Questions and answers for biological medicinal products
about 20 hours ago
Questions and answers for biological medicinal products
Human medicines European public assessment report (EPAR): Tyruko, natalizumab, Date of authorisation: 22/09/2023, Revision: 4, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Tyruko, natalizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Celldemic, zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures), Date of authorisation: 19/04/2024, Revision: 1, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Celldemic, zoonotic influenza vaccine (H5N1)...
Human medicines European public assessment report (EPAR): Incellipan, pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures), Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Incellipan, pandemic influenza vaccine (H5N1)...
Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Gobivaz, golimumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Suboxone, buprenorphine,naloxone, Date of authorisation: 26/09/2006, Revision: 24, Status: Withdrawn
about 22 hours ago
Human medicines European public assessment report (EPAR): Suboxone, buprenorphine,naloxone, Date of authorisation...
Human medicines European public assessment report (EPAR): Tolvaptan Accord, tolvaptan, Revision: 2, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Tolvaptan Accord, tolvaptan, Revision: 2...
Human medicines European public assessment report (EPAR): Yuflyma, adalimumab, Date of authorisation: 11/02/2021, Revision: 22, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Yuflyma, adalimumab, Date of authorisation...
Suboxone : EPAR - Procedural steps taken before authorisation
1 day ago
Suboxone : EPAR - Procedural steps taken before authorisation